After nearly a decade of expensive, hit-and-miss investments, Mohammed bin Salman is overseeing a behind-the-scenes restructuring of the kingdom’s all-important wealth fund.
Category: Politics and Government
-
Trump’s Tariffs Sent Trade Plummeting in August
The steep tariffs President Trump issued in August led to a significant contraction in imports and the trade deficit, newly released data shows.
-
The Most Impactful Political Handbag Since Mrs. Thatcher’s
Sanae Takaichi, the new prime minister of Japan, makes a statement about work — with style.
-
Former Fed Official Violated Trading Rules, Disclosures Show
Adriana D. Kugler, who stepped down as a governor in August, reported trades in stocks, including Apple and Southwest Airlines, in 2024.
-
The Global Climate Leadership Vacuum
The United States is largely absent from the United Nations climate negations in Brazil. So who is stepping up?
-
Tiny Love Stories: ‘Ted and I Are Implausible Friends’
Modern Love in miniature, featuring reader-submitted stories of no more than 100 words.
-
‘South Park’ Takes On Trump and Wins Bigly
“It’s not that we got all political,” said Trey Parker, one of the show’s creators. “It’s that politics became pop culture.”
-
Airlines Rush to Prepare for Federal Reductions in Flights
Airline planning and scheduling teams went into overdrive to identify which flights to cut while minimizing consequences for customers, pilots, flight attendants and the bottom line.
-
Obesity Drugs May Drop to as Little as $150 a Month
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
-
Was Mamdani’s Win a Referendum on Capitalism?
Democrats won big nationwide. But Zohran Mamdani’s victory raises questions about whether Democrats and voters are embracing populism.
-
F.D.A. Drug Unit Chief Is Placed on Leave, and Cites a ‘Toxic’ Environment
The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.